Fred Hutchinson Cancer Rsrch is categorized under Commercial Medical Research in Seattle, WA .
Fred Hutchinson Cancer Rsrch was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 5417112 by the NAICS.
If you are seeking more information, feel free to contact Larry Corey, President at the company’s single location by writing to 1100 Fairview Avenue North, Seattle, Washington WA 98109 or by phoning (206) 667-5000. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Fred Hutchinson Cancer Rsrch |
| Contact Person: | Larry Corey, President |
| Address: | 1100 Fairview Avenue North, Seattle, Washington 98109 |
| Phone Number: | (206) 667-5000 |
| Website Address: | fhcrc.org |
| Annual Revenue (USD): | Unknown |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 5417112 |
| Share This Business: |
Fred Hutchinson Cancer Rsrch was started in 0 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 5417112. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Larry Corey, President for inquiries that concern Fred Hutchinson Cancer Rsrch by calling the company number (206) 667-5000, as your correspondence is most welcome. Additionally, the physical location of the single location of Fred Hutchinson Cancer Rsrch can be found at the coordinates 47.629256,-122.330122 as well as the street address 1100 Fairview Avenue North in Seattle, Washington 98109.
For its online presence, you may visit Fred Hutchinson Cancer Rsrch’s website at fhcrc.org and engage with its social media outlets through on Twitter and on Facebook.